Novo Nordisk: The European Medicines Agency's Human Medicines Products Committee recommended that the European Union approve Frehemgo®, the first coagulation factor VIII analog drug that can be administered monthly.

Zhitongcaijing · 2d ago
Novo Nordisk: The European Medicines Agency's Human Medicines Products Committee recommended that the European Union approve Frehemgo®, the first coagulation factor VIII analog drug that can be administered monthly.